News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Artemis Pharmaceuticals GmBh (EXEL) and Taconic Farms, Inc. Acquire Chemical Genetics Technology From CGI Pharmaceuticals, Inc.



5/2/2007 11:54:32 AM

HUDSON, N.Y. & COLOGNE, Germany--(BUSINESS WIRE)--Taconic Farms, Inc. (Hudson, NY, USA) and Artemis Pharmaceuticals GmbH (Cologne, Germany) today announced that they have jointly acquired the worldwide rights to the ASKA technology from CGI Pharmaceuticals Inc. (“CGI,” Branford, CT, USA). Representing a cutting-edge approach to in vivo kinase-related drug discovery, ASKA technology is based on the replacement of a normal kinase with a selectively modified kinase or “ASKA” (Analogue Sensitive Kinase Allele) in genetically modified mice.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES